Mission:

Equal reimbursement parity for anticancer regimens regardless of delivery method including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transplantation, etc.


The Patients Equal Access Coalition (PEAC) is a patient focused coalition of organizations representing patients, health care professionals, care centers, and industry collaboratively joined together to ensure that cancer patients have equality of access (and equality of insurance coverage) to all approved anticancer regimens including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transplantation, etc. PEAC believes that every cancer patient should have access to the anticancer regimens recommended by their physicians and should not suffer from cost discrimination based on the type of therapy provided or the mechanism of delivery.

Share Your Story

If unequal reimbursement has affected you or someone you know, please write a few sentences that tell a personal story.

Write to Congress

Contact your Representative to tell them how important access to patient-administered anticancer drugs is for the myeloma community.

Patient Access

The Patients Equal Access Coalition has endorsed the Cancer Drug Coverage Parity Act which creates parity for coverage of patient administered and physician administered anticancer treatments.

Due to an outdated insurance benefit design, cancer patients across the country are not able to afford their oral anticancer medications. Please take a moment to hear from the patients themselves, and learn about what we are doing to find a solution.

News:


The PEAC Applauds a New Bill to Improve Access to Oral Cancer Drugs

Washington, DC, June 11, 2015 – Today the Patients Equal Access Coalition (PEAC) commends Congressmen Leonard Lance (R-NJ-7th District) and Brian Higgins (D-NY-26th District) and Senators Kirk (R-IL) and Franken (D-MN) on the introduction of the Cancer Drug Coverage Parity Act of 2014, H.R. 2739/S. 1566. This bill is a critical step toward improving access to anticancer treatments by requiring insurance companies to cover patient-administrated and physician-administered anticancer drugs at the same cost to patients.



Click Here to Read More.

Click here to watch Rep. Higgins talking about HR 2739.